Furthermore, here we demonstrated the capability of Gal-1 to trans-bridge core M1 α-DG glycoconjugates with various laminins in microarray, providing an additional insight on the therapeutic application of this galectin in muscular dystrophy. The gene discussed is GAL; the disease is muscular dystrophy.